Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Multicentre, Randomized Study of Insulin Glargine + Prandial Insulin Glulisine Associated With a Telemedicine System for Carbohydrates Counting vs. Insulin Glargine + Prandial Insulin Glulisine Associated With Common Practice

NCT01192711 is registered in ClinicalTrials.gov with Consorzio Mario Negri Sud as lead sponsor.

NCT NCT01192711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01192711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Multicentre, Randomized Study of Insulin Glargine + Prandial Insulin Glulisine Associated With a Telemedicine System for Carbohydrates Counting vs. Insulin Glargine + Prandial Insulin Glulisine Associated With Common Practice
Lead sponsor
Consorzio Mario Negri Sud
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2009
Completion date
Not reported
Enrollment
130 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes